S0438: Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

This study is ongoing, but not recruiting participants.

Study NCT00281957 Information provided by Southwest Oncology Group

First Received: January 24, 2006 Last Updated: July 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given